Innova Captab IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 570.00 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. ICICI Securities , Jm Financial are the merchant bankers of Innova Captab IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th June 2022.
Innova Captab IPO posted revenues of ₹ 937.48 crores and PAT of ₹ 70.36 crores in FY24 on annualised basis.Financial results of Innova Captab IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Jun-23 | FY23 | FY22 | FY21 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 1086.10 | 704.40 | 575.40 | 369.60 | |
Net Worth | 294.20 | 276.40 | 208.50 | 144.70 | |
Total Debt | 441.90 | 235.10 | 198.10 | 45.00 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
233.20
932.80 |
926.30 | 800.50 | 410.60 | |
EBITDA
EBITDA on annualised basis |
32.40
129.60 |
122.80 | 98.90 | 55.80 | |
PAT
PAT on annualised basis |
17.50
70.00 |
67.90 | 63.90 | 34.50 |
Innova Captab IPO PAT Margin is 7.50 % , ROCE (Return on Capital Employed) is 3.75 % as per latest financial. The below table shows Innova Captab IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Jun-23 | FY23 | FY22 | FY21 |
---|---|---|---|---|
EBITDA Margin (%) | 13.89 | 13.26 | 12.35 | 13.59 |
PAT Margin (%) | 7.50 | 7.33 | 7.98 | 8.40 |
EPS (₹) | 3.67 | 14.16 | 13.32 | 7.19 |
ROE (%) | 5.95 | 24.57 | 30.65 | 23.84 |
ROCE (%) | 3.75 | 22.61 | 23.46 | 26.54 |
ROA (%) | 1.61 | 9.64 | 11.11 | 9.33 |
Debt to Equity | 1.50 | 0.85 | 0.95 | 0.31 |
The market Capitalisation of Innova Captab IPO is ₹ 2563.70 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Innova Captab IPO prospectus highlights an Return on Equity (ROE) of 5.95 % , Return on Assets (ROA) of 1.61 %, and an EBITDA Margin of 13.89 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Innova Captab IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Innova Captab IPO is ₹ 2563.70 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Innova Captab IPO has a Price-to-Earnings (PE) ratio of 22.02 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Innova Captab IPO reported revenue of ₹ 937.48 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Innova Captab IPO provide insights into sales growth, market demand, and business scalability.
Innova Captab recorded an EBITDA of ₹ 129.60 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Innova Captab Profit After Tax (PAT) is ₹ 70.00 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Innova Captab operates in Pharmaceutical and Pharmaceutical Company. The Issue is listed on BSE,NSE in Dec, 2023. Innova Captab IPO size was 570.00 with Issue price of 448.00 .
Merchant Banker(s) of Innova Captab IPO: ICICI Securities Limited , Jm Financial Limited
Innova Captab IPO subscription was 55.26 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Innova Captab IPO listed at a listing price of 545.15 against the offer price of 448.00.
The current market price of Innova Captab is 853.80.
Why Us?